FitLife Brands Inc. (FTLF)
FTLF trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$9.07
-1.73% on the day
Market cap
$85.2M
Micro cap
Revenue · 2025
$81.5M
No prior year to compare
Net income · 2025
$6.3M
7.8% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/1374328/000143774926010680/0001437749-26-010680-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | FTLF on Nasdaq |
| Sector | Health Care |
| Industry | Medicinal Chemicals and Botanical Products |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001374328 |
| SEC industry code | Medicinal Chemicals & Botanical Products |
| Incorporated in | NV |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $81.5M |
| Net income | $6.3M |
| Operating income | $3.0M |
| Net margin | 7.8% |
| Operating margin | 3.6% |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | $106.3M |
| P/E (computed) | 13.5× |
| P/S (computed) | 1.0× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM S-3 | S-3 | 2024-11-14 |
| Latest annual report FORM 10-K/A | 10-K/A | 2026-04-21 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-08-13 |
| Latest current report FORM 8-K | 8-K | 2026-09-09 |
| Latest proxy FORM DEFA14A | DEFA14A | 2026-06-26 |
Source: SEC EDGAR submissions feed, 539 recent filings. All filings on EDGAR.
Peers in Medicinal Chemicals and Botanical Products
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ISPR | Ispire Technology Inc. | $1.45 | -1.36% | $83.7M |
| MDWD | MediWound Ltd. | $12.22 | -2.71% | $157.8M |
| BTMD | Biote Corp. | $1.04 | -8.77% | $37.4M |
| NAGE | Niagen Bioscience Inc. | $2.58 | -1.90% | $204.1M |
| ACB | Aurora Cannabis Inc. Common Shares | $4.29 | -1.38% | $265.8M |
| SNDL | SNDL Inc. Common Shares | $1.16 | -0.85% | $285.5M |
| USNA | USANA Health Sciences Inc. | $15.46 | +3.41% | $285.6M |
| CGC | Canopy Growth Corporation Common Shares | $0.7625 | +0.66% | $322.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier